← Back to headlines
Nanyang Biologics Advances $1.5 Billion Nasdaq Listing Plan
Nanyang Biologics is moving forward with its plan for a $1.5 billion Nasdaq listing. This significant step indicates the company's ambition to expand its presence in the global financial markets.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
